Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Hemostemix
491
Hemostemix
Technology
Biotechnology
Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies for medical conditions not yet adequately addressed.
Suggest edits
Founded
2006
Raised
$4.4M
Follow us
Companies in the same industry
Cartiva, Inc.
Alfacyte Ltd
JuiceInnov8
Danforth Center
Fusion Pharmaceuticals
Artizan Biosciences
Vermillion
Affigen
Hazel Technologies
MonTa Biosciences
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$4,400,000
Debt financing - 2017
Wood Capital
Team Size
2
Employees
I work here
Location
Canada
Headquarters
Explore Canada
$4,400,000
Debt financing
PE HUB
Hemostemix nets $4.4 mln in debt funding, aims for $8 mln more
Stock markets
Legal
Privacy
